Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06024187 | Cold Dissection Versus Electrocautery Dissection in Endoscopic Nipple-Sparing Mastectomy and Immediate Implant-Based Reconstruction: A Randomized Controlled Trial | recruiting | N/A | 566 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT03449264 | Development of Clinical and Biological Database(BCBInstitut) | recruiting | N/A | 4,000 | Institut du Cancer de Montpellier - Val d'AurelleOTHER |
| 1 |
| Feb 12, 2025 |
| clinicaltrials |
| NCT04282122 | Clinical Database of Safe Personalized Adjuvant Breast Radiotherapy Based on Individual Radiosensitivity(SAHARA-01) | recruiting | — | 500 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04356209 | Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic " Patient Reported Outcome ") on Breast-related Quality of Life(PRAVACUR-02) | recruiting | Phase 2 | 105 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04744506 | Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy | recruiting | N/A | 126 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT05056350 | Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work(VISIBILITE) | recruiting | N/A | 25 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT06818370 | The Effect of Coconut Oil on Alopecia | recruiting | N/A | 86 | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT06069115 | Radiotherapy Exposed Lung Injury: Effect on Functioning - Cohort(RELIEF-COHORT) | recruiting | — | 200 | Meshalkin Research Institute of Pathology of CirculationNETWORK | 1 | Feb 11, 2025 | clinicaltrials |
| NCT06671262 | Neoadjuvant Toripalimab and Radiotherapy Treatment in N+ HR+ Breast Cancer(NEOTRIO-HR) | recruiting | Phase 2 | 74 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT06819215 | Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 188 | Zhejiang Yangli Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Feb 11, 2025 | clinicaltrials |
| NCT06374745 | An Integrated Algorithm for Surgical Intervention in Chronic Lymphedema After Breast Cancer Treatment: The Basel Lymphedema Protocol | recruiting | — | 500 | University Hospital, Basel, SwitzerlandOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT06202118 | A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients. | recruiting | N/A | 10 | Alpha Tau Medical LTD.INDUSTRY | 1 | Feb 7, 2025 | clinicaltrials |
| NCT06741540 | Effects of TDCS Intervention on Neoadjuvant Chemotherapy in Breast Cancer Patients with Mild to Moderate Depression | recruiting | N/A | 60 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT06813456 | Implementation of Solid Digital PCR to Support Gold-standard Methods for Evaluation of HER2 Amplification Status: Focus on HER2-low Subtype(CRANBERRY) | recruiting | — | 234 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT03730922 | Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy | recruiting | N/A | 590 | Danish Breast Cancer Cooperative GroupOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT06786026 | QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC | recruiting | Phase 2 | 60 | Fudan UniversityOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT06489665 | Imaging Quality and Potential Clinical Relevance of Phase Contrast Mammography In-vivo: a Single-center, Prospective Study | recruiting | — | 350 | University of ZurichOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT06106529 | REDucing Hot FLASHes in Women Using Endocrine Therapy.(REDFLASH) | recruiting | Phase 3 | 260 | Reinier de Graaf GroepOTHER | 1 | Feb 4, 2025 | clinicaltrials |
| NCT06805812 | Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study(PALMARES-2) | recruiting | — | 3,500 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT03740503 | Genomic Investigation of Unusual Responders(GENIUS) | recruiting | — | 100 | University Health Network, TorontoOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT05388149 | Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual Disease | recruiting | Phase 2 | 15 | University Health Network, TorontoOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT05912569 | Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCIS | recruiting | N/A | 84 | Seoul National University HospitalOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT04872166 | A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer | recruiting | Phase 1 | 112 | Edgewood Oncology Inc.INDUSTRY | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06793553 | Induction Therapy of PTX+BV Followed by Atezolizumab+Nab-PTX for PD-L1+ TNBC(INDUCE) | recruiting | Phase 2 | 106 | Japan Breast Cancer Research GroupOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06796166 | The Impact of AI- Supported Education in Mastectomy Patient(AI-ME) | recruiting | N/A | 40 | Bezmialem Vakif UniversityOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT06324721 | Who and Why do Patients Report Lymphedema After Breast Cancer Treatment Without an Objective Measurable Swelling(LymphSens) | recruiting | N/A | 230 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 29, 2025 | clinicaltrials |
| NCT06215027 | The Effects of Dance for Breast Cancer Patients Undergoing Surgical Treatment | recruiting | N/A | 30 | AC Camargo Cancer CenterOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT06793332 | BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC(BALISTA) | recruiting | Phase 2 | 39 | Fudan UniversityOTHER | 1 | Jan 27, 2025 | clinicaltrials |
| NCT05475678 | Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer | recruiting | Phase 2 | 369 | Zhenzhen LiuOTHER_GOV | 1 | Jan 23, 2025 | clinicaltrials |
| NCT06786663 | MALE Mamm Organoids | recruiting | — | 7 | Regina Elena Cancer InstituteOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT06786949 | Night-shift Work and Breast Cancer(BC-NSW-02/2023) | recruiting | — | 6,000 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT04608357 | Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients | recruiting | — | 25 | Sunnybrook Health Sciences CentreOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT06642428 | Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients with Breast Cancer | recruiting | N/A | 140 | Jiuda ZhaoOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06642441 | Effect of Vitamin D Supplementation on Chemotherapy Side Effects After Adjuvant Chemotherapy for Breast Cancer | recruiting | N/A | 100 | Jiuda ZhaoOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06780748 | Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients | recruiting | Phase 2 | 30 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06772935 | Electroacupuncture Treatment of Peripheral Neuropathy After Taxane Chemotherapy for Breast Cancer(CIPN) | recruiting | N/A | 162 | Affiliated Hospital of Qinghai UniversityOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06773533 | Registry of Adjuvant Hormone-blockade Breast Cancer Patients Evaluated for Bone Mineral Metabolism | recruiting | — | 3,000 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06770296 | The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical Study | recruiting | Phase 1 | 200 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT06171360 | A Study of the Gut Microbiome in Hormone Receptor-positive HER2-negative Breast Cancer Treated With CDK4/6 Inhibitors(CICLIBIOME) | recruiting | — | 100 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Jan 10, 2025 | clinicaltrials |
| NCT06492005 | A Clinical Study of 9MW2821 (and PD-1 Inhibitor) in Locally Advanced or Metastatic Triple-Negative Breast Cancer | recruiting | Phase 2 | 160 | Mabwell (Shanghai) Bioscience Co., Ltd.INDUSTRY | 1 | Jan 10, 2025 | clinicaltrials |
| NCT06765252 | Effect of Genetic Polymorphism on Capecitabine-Induced Toxicity in Egyptian Cancer Patients | recruiting | — | 80 | Ain Shams UniversityOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT06553235 | RESET-BRAIN: REhabilitation of SleEp and CogniTive Impairment in BReast Cancer Survivors Using an App-based Intervention(RESET-BRAIN) | recruiting | N/A | 84 | Aarhus University HospitalOTHER | 1 | Jan 8, 2025 | clinicaltrials |
| NCT06155305 | Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer(ONAC) | recruiting | — | 58 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jan 7, 2025 | clinicaltrials |
| NCT06759714 | "Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients" | recruiting | — | 100 | Ain Shams UniversityOTHER | 1 | Jan 6, 2025 | clinicaltrials |
| NCT06757621 | Hypofractionated Postoperative Regional Nodal Irradiation for Patients With Intermediate-risk Breast Cancer | recruiting | Phase 3 | 3,142 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jan 3, 2025 | clinicaltrials |
| NCT06754059 | Pyrotinib Combined With Trastuzumab for Maintenance Therapy After First-line TH (P) Therapy for HER2+ABC | recruiting | — | 60 | zhangjieOTHER | 1 | Jan 1, 2025 | clinicaltrials |
| NCT04843865 | TCM as an Adjuvant Treatment in Breast Cancer Patients | recruiting | N/A | 30 | Universiti Tunku Abdul RahmanOTHER | 1 | Dec 31, 2024 | clinicaltrials |
| NCT05939830 | Omission of ALND in Breast Cancer Patients With Axillary pCR | recruiting | N/A | 92 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Dec 30, 2024 | clinicaltrials |
| NCT06726889 | Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients | recruiting | — | 104 | European Institute of OncologyOTHER | 1 | Dec 20, 2024 | clinicaltrials |
| NCT05673304 | Preoperative Boost Associated With Neoadjuvant Chemotherapy in Luminal B Breast Cancer | recruiting | N/A | 30 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Dec 18, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Feb 13, 2025source: clinicaltrials